Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection

Contraception

Volumn 70, Issue 1, 2004, Pages 19-23

  Morroni, Chelsea ^a   Grams, Morgan ^b   Tiezzi, Lorraine ^c   Westhoff, Carolyn ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Howard Hughes Medical Institute   (United States)

^c Mailman School of Public Health   (United States)

Author keywords

Depot medroxyprogesterone acetate; DMPA; Hormonal contraception; Injectable contraception; Reproductive health services

Indexed keywords

ESTRADIOL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ABSTINENCE; ADOLESCENT; ADULT; ARTICLE; CLINICAL PROTOCOL; CONDOM; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH SERVICE; HORMONAL CONTRACEPTION; HUMAN; MENSTRUAL CYCLE; METHODOLOGY; OUTPATIENT CARE; PATIENT SATISFACTION; PREGNANCY; REPRODUCTIVE HEALTH; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERVIEWS; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUATION; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2942672489     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.02.007     Document Type: Article

References (11)

1. Petta C.A., Faundes A., Dunson T., et al. Timing of onset of contraceptive effectiveness in Depo-Provera users Part 1. Changes in cervical mucus. Fertil Steril. 69:1998;252-257
2. Petta C.A., Faundes A., Dunson T., et al. Timing of onset of contraceptive effectiveness in Depo-Provera users Part 2. Effects on ovarian function. Fertil Steril. 70:1998;817-820
3. nd ed:2000;World Health Organization, Geneva
4. Kaunitz A. Injectable long-acting contraceptives. Clin Obstet Gynecol. 44:2001;73-91
5. Stanback J., Thompson A., Hardee K., et al. Menstruation requirements a significant barrier to contraceptive access in developing countries. Stud Fam Plann. 28:1997;245-250
6. Stanback J., Nutley T., Gitonga J., et al. Menstruation requirements as a barrier to contraceptive access in Kenya. East Afr Med J. 76:1999;124-126
7. Hardee K., Clyde M., McDonald O.P., et al. Accessing family planning service delivery practices the case of private physicians in Jamaica. Stud Fam Plann. 26:1995;338-349
8. McFarlane C., Hardee K., DuCasse M., et al. The quality of Jamaica public sector and NGO family planning services: perspectives of providers and clients. 1996;Family Health International, Research Triangle Park (NC)
9. Twum-Baah K.A., Stanback J. Provider rationales for restrictive family planning service practices in Ghana. Final report. 1995;Ghana Statistical Service and Family Health International, Research Triangle Park (NC)
10. Westhoff C., Kerns J., Morroni C., et al. Quick start a novel oral contraceptive initiation methods. Contraception. 66:2002;141-145
11. Westhoff C., Morroni C., Kerns J., et al. Bleeding patterns after immediate versus conventional oral contraceptive initiation a randomized controlled trial. Fertil Steril. 79:2003;322-329